RAC1 and ovarian carcinoma: Numerous previous studies have shown that FDPS is strongly associated with tumor drug resistance (For example, FDPS modulates platinum sensitivity in human ovarian cancer [21]; Disruption of the FDPS/Rac1 axis increases the sensitivity of radiation therapy for pancreatic ductal adenocarcinoma [19]).